Clean Science & Technology , a prominent player in the Indian chemical industry, has announced a series of significant inter-se share transfers among its promoter group members. The company disclosed this information to the stock exchanges on November 19, 2025, in compliance with regulatory requirements.

Key Transfers

The proposed transfers, scheduled to take place on or after November 26, 2025, involve several promoter group members. The most notable transactions include:

1. Nilima Krishnakumar Boob is set to acquire a total of 66,29,986 equity shares (6.24% stake) from Prasad Krishnakumar Boob and Pooja Vivek Navandar.
2. Asha Ashok Boob will receive 86,19,490 equity shares (8.11% stake) from Parth Ashok Maheshwari and Nidhi Mohunta.
3. Siddhartha Ashok Sikchi will acquire 26,00,000 equity shares (2.45% stake) from Ashok Ramnarayan Boob.

Transaction Details

The company provided a detailed breakdown of the proposed transfers:

Regulatory Compliance

Clean Science & Technology emphasized that these transfers fall under the exemption provided in Regulation 10(1)(a)(i) and (ii) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This exemption applies to inter-se transfers among qualifying persons, such as immediate relatives and promoter group members.

Impact on Shareholding

The company stated that the aggregate holding of the Promoter and Promoter Group will remain unchanged before and after these inter-se transactions. This indicates that the transfers are primarily a redistribution of shares within the promoter group rather than a change in overall control.

Rationale for Transfers

The company mentioned that the overall rationale is "to streamline the Family's assets and businesses." This suggests a strategic realignment of ownership within the promoter family.

Market Implications

As these transfers are within the promoter group and do not alter the group's overall stake in the company, they are unlikely to have a significant impact on the market price or control of Clean Science & Technology. However, investors and market analysts may closely watch for any subsequent changes in the company's management or strategic direction following this realignment of promoter shareholdings.

Clean Science & Technology has assured compliance with all relevant regulations, including those under SEBI's Listing Obligations and Disclosure Requirements (LODR) and Prohibition of Insider Trading Regulations. The company will execute these transfers through gift deeds, with no monetary consideration involved.

Shareholders and potential investors are advised to monitor any further announcements from the company regarding the completion of these transfers and any potential implications for the company's governance or strategy.

Clean Science & Technology , a leading specialty chemicals manufacturer, reported a 5% sequential decline in standalone revenue to INR 206.00 crores in Q2 FY26. The company faced headwinds from lower sales in established products and challenging market conditions, particularly in China.

Key Financial Highlights

• Standalone revenue declined 5% sequentially and 8% year-on-year to INR 206.00 crores
• EBITDA margins remained resilient at 44% despite revenue moderation
• Standalone EBITDA was INR 90.00 crores, down 10% quarter-on-quarter
• Standalone PAT stood at INR 65.00 crores, a 15% decrease quarter-on-quarter

Performance Analysis

The revenue decline was primarily driven by lower sales in established products, with the top four products contributing 80% to standalone revenue, down from 84% in the previous quarter. The company attributed the lower sales to customers experiencing sharp price declines in their end products due to competitive pressure from Chinese suppliers, leading to slower procurement.

Mr. Siddharth Sikchi, Executive Director of Clean Science & Technology, commented on the market dynamics, stating, "China is a very tricky environment. And it is sometimes very difficult to predict exactly what is happening there."

HALS Segment Shows Promise

The HALS (Hindered Amine Light Stabilizers) segment demonstrated positive momentum:

• Monthly run-rate volumes averaged 260 tons per month, representing over 25% growth compared to the previous quarter
• Material margins for the HALS portfolio improved to 35% from 31%
• The company commercialized HALS 2020 and barbituric acid during the quarter

New Product Developments

Clean Science & Technology is making progress on new product initiatives:

• Performance Chemical 1 is undergoing chemical trials with satisfactory results, and commercialization is expected this month
• The facility has an installed capacity of about 10,000 tons with potential revenue of INR 300.00 crores at current prices over a 3-year period by FY28
• The company expects a 50-50 split between domestic and international markets for this new product

Outlook

While the company faces near-term challenges, management remains focused on growth initiatives:

• Expect sequential growth in the HALS segment for Q3 and Q4
• Anticipate contributions from barbituric acid and Performance Chemical 1 starting in Q4
• Maintain a strategy to preserve market share in established products

Clean Science & Technology continues to navigate a complex global market environment, balancing challenges in established products with growth opportunities in new segments. The company's ability to maintain margins and progress on new product initiatives suggests resilience in the face of market headwinds.

Q2 FY26 Financial Performance

As Clean Science & Technology adapts to evolving market conditions, investors and industry observers will be watching closely to see how the company's strategic initiatives unfold in the coming quarters.